Environment

A healthy planet is the foundation of our human health, giving us the clean air, water, and resources we need to thrive. Yet, climate change, pollution, and biodiversity loss are directly impacting our well-being, leading to increased health risks.

At Chiesi, we are committed to tackling these issues -reducing emissions, conserving resources, and combating climate change -to build a sustainable future where both the planet and its people can flourish for generations to come.

Our path to Net Zero

Our GHG emissions reduction targets align with the Paris Agreement's most ambitious goal of limiting global temperature rise to 1.5°C above pre-industrial levels by 2100.

Chiesi’s Net Zero strategy emphasizes minimizing carbon-intensive processes to reach our goals without relying heavily on emissions removal.

Starting in 2019, we committed to achieving carbon neutrality for our operations by 2030 and for our value chain by 2035, supported by Scope 1, 2 and 3 reduction targets validated by the Science Based Targets initiative (SBTi) in April 2021.

 

Scope 1: All direct emissions generated through company-owned facilities and vehicle fleets.

 

Scope 2: Emissions released through purchased energy, such as electricity and heating.

 

Scope 3: Indirect emissions such as employee use of sold products, purchased goods and services, and business travel.

With the introduction of the SBTi Net Zero Standard, which requires a minimum 90% reduction in absolute emissions and limits reliance on carbon removal methods to no more than 10%, Chiesi embraced the more stringent Net Zero emissions goal.
In October 2024, our Net Zero greenhouse gas reduction targets were also approved by SBTi.

Chiesi commits to reach Net Zero GHG emissions across the value chain by 2035.

Explore our detailed strategy for achieving this goal in our Climate Transition Plan

Action Over Words

With the purpose of promoting accountability and climate action, in 2021 we launched the #ActionOverWords campaign. It highlights Chiesi’s 2019 investment of €350 million to reduce the carbon footprint of pressurized metered dose inhalers (pMDIs).

This initiative involves developing new formulations of a platform of currently available pMDI products replacing the current hydrofluorocarbon (HFC) propellant (HFA 134a) with a low global warming potential (GWP) propellant (HFA 152a).

By using the new propellant, Chiesi anticipates reducing the product’s carbon footprint by up to 90% compared to the current ones, while still supporting Dry Powder Inhaler (DPI) technology to provide patients with a variety of treatment options tailored to their individual needs.

Climate Advocacy

As part of our commitment to emissions reduction, Chiesi recognizes the importance of taking a public stance to raise awareness about the climate crisis and drive positive social change and legislation.

• Chiesi had already joined the Carbon Disclosure Project (CDP) and achieved an “A” rating in 2021 and 2022. In 2023, after the Climate Change questionnaire of the CDP had considerably been revised, Chiesi still proudly received an “A-” rating.

• Chiesi Germany introduced WeACT Con, a fresh congress format highlighting the connections between health, environment, and sustainability. WeACT Con brought together diverse healthcare figures, including doctors and policymakers, for a two-day event in Berlin.

• With a focus on understanding how healthcare impacts climate change and vice versa, the congress aimed to explore comprehensive solutions and perspectives through collaboration and open discussion.

• Supported by Chiesi, an Economist Impact report, titled Cleaner air, clearer lungs, better lives, revealed the significant impact of climaterelated factors on lung health. The report explores how air quality affects health disparities and lung health, drawing from the experiences of lung disease patients in the UK, Italy, Spain, Germany, and France. It underscores the broader impact on overall well-being and advocates for comprehensive health policy solutions. Dive into the report here.

• Chiesi participated in “The Climate and Us” series by BBC StoryWorks and the Global Climate and Health Alliance. This series, launched during COP 28, examines the severe impact of climate change on global human health, particularly affecting those with respiratory conditions.

   

  In our sponsored episode, “How redesigning inhalers could reduce their environmental impact”, we underscore the urgent need to minimize inhalers’ environmental footprint. Lara, an asthma patient, shares her firsthand experience of the health risks posed by air pollution. Click here to watch Lara’s story.